(Q35135945)

6 August 2017

1 reference

title

Cognitive-behavioral therapy for panic disorder: a review of treatment elements, strategies, and outcomes (English)

1 reference

cognitive behavioral therapy

6 August 2017

Cognitive-Behavioral Therapy for Panic Disorder: A Review of Treatment Elements, Strategies, and Outcomes (English)

0 references

1 reference

1 reference

inferred from title

author name string

Nadine Recker Rayburn

series ordinal

1

1 reference

6 August 2017

Michael W Otto

series ordinal

2

1 reference

6 August 2017

Michael W. Otto

series ordinal

2

0 references

publication date

1 May 2003

1 reference

6 August 2017

May 2003

0 references

published in

C N S Spectrums

1 reference

6 August 2017

volume

8

1 reference

6 August 2017

issue

5

1 reference

6 August 2017

05

0 references

page(s)

356-362

1 reference

Pretreatment attrition in a comparative treatment outcome study on panic disorder

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A crossover study of focused cognitive therapy for panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A comparison of cognitive therapy, applied relaxation and imipramine in the treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Combined pharmacological and behavioral treatment for agoraphobia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Dismantling cognitive-behavioral treatment for panic disorder: questioning the utility of breathing retraining

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Cognition-behaviour links in the persistence of panic.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Stories and metaphors in cognitive-behavior therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Prevention of panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Empirically supported treatments for panic disorder: costs, benefits, and stepped care

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Psychological approaches to panic disorder: a review

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Longitudinal outcome with pharmacotherapy in a naturalistic study of panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case series.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A cognitive approach to panic.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Discontinuation of benzodiazepine treatment: efficacy of cognitive- behavioral therapy for patients with panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Maintenance of remission following cognitive behavior therapy for panic disorder: Possible deleterious effects of concurrent medication treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Rate of improvement during cognitive-behavioral group treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Cognitive behavioral treatment compared with nonprescriptive treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Two-year follow-up of exposure and imipramine treatment of agoraphobia

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Brief treatment of emergency room patients with panic attacks

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

https://api.crossref.org/works/10.1017%2FS1092852900018617

1 reference

7 January 2021

Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Follow-up of agoraphobic patients treated with exposure in vivo or applied relaxation.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A maintenance program for behavioral treatment of anxiety disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Transporting an empirically supported treatment for panic disorder to a service clinic setting: a benchmarking strategy.

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A meta-analysis of treatments for panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

A comparison of alprazolam and behavior therapy in treatment of panic disorder

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

Long-term outcome in cognitive-behavioral treatment of panic disorder: Clinical predictors and alternative strategies for assessment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852900018617

7 January 2021

10.1017/S1092852900018617

Identifiers

DOI

0 references

1 reference